UKOMNAS PDVF study materials
UKOMNAS PDVF study resources

UKOMNAS PDVF cheat sheet

UKOMNAS PDVF · Keep the key ideas within reach.

Quick reference

Fundamentals of Vascular Access and the PDVF Role

  • Vascular access device (VAD) categories: peripheral cannula, midline catheter, peripherally inserted central catheter (PICC), centrally inserted central catheter (CICC), implanted port, tunnelled catheter.

  • PDVF (peripherally inserted device / vascular access) practitioner scope typically covers ultrasound-guided peripheral and central insertion, tip confirmation, dressing and catheter care, and complication triage under local policy.

  • Device selection rule: match dwell time, infusate characteristics (osmolarity, pH, vesicant status), and vessel suitability; peripheral cannula for short therapy, midline for weeks, PICC/CICC for weeks to months.

  • Osmolarity threshold for peripheral administration is commonly cited as ≤900 mOsm/L; pH range for peripheral tolerance is approximately 5–9.

  • Vesicant drugs (e.g. anthracyclines, vinca alkaloids, some contrast agents) require central access with confirmed tip position before infusion.

  • The PDVF role is governed by local competency frameworks, delegation, and scope of practice; insertion without documented competence and consent is outside scope.

  • Bundle concept: insertion bundle (hand hygiene, maximal barrier, skin antisepsis, optimal site selection, daily review) plus maintenance bundle reduces catheter-related bloodstream infection.

  • Accountability: the inserting practitioner remains responsible for documentation, tip verification, and escalation of abnormal findings to the treating team.

Quick reference

Anatomy, Physiology, and Vascular Assessment

  • Upper limb venous drainage: cephalic vein (lateral, into axillary), basilic vein (medial, joins brachial veins to form axillary), median cubital vein connecting them at the cubital fossa.

  • Cephalic vein is preferred for PICC when suitable because of straighter course; basilic vein has a sharper angle at the axillary junction and lies near the brachial artery and median nerve.

  • The brachial artery and median nerve run close to the basilic vein in the antecubital fossa; puncture risk requires ultrasound identification before needle advancement.

  • Central venous anatomy: superior vena cava formed by union of right and left brachiocephalic veins; SVC drains into right atrium at the cavoatrial junction.

  • Cavoatrial junction is the ideal central tip landmark, approximately 2–3 cm below the carina on chest radiograph.

  • Vein assessment: diameter, depth, compressibility, valve presence, tortuosity, and continuity; a compressible anechoic lumen with thin walls indicates a patent vein.

  • Arterial versus venous ultrasound: arteries are non-compressible, pulsatile, thicker-walled; veins compress fully with light probe pressure.

  • Patient factors affecting vessel calibre: hydration, previous cannulation, chemotherapy, limb surgery, lymphoedema, and renal fistula protection (avoid fistula arm).

Quick reference

Pre-procedural Patient Evaluation and Informed Consent

  • Pre-procedure assessment includes indication, therapy duration, infusate properties, allergy history (chlorhexidine, lidocaine, latex), anticoagulation, and coagulopathy.

  • Coagulation thresholds are local-protocol dependent; typical guidance for PICC insertion is INR ≤1.5 and platelet count ≥50 ×10⁹/L, with individual risk assessment for higher values.

  • Informed consent elements: nature of procedure, benefits, risks (infection, thrombosis, bleeding, malposition, pneumothorax for CICC), alternatives, and right to withdraw.

  • Consent must be obtained by a competent practitioner, documented, and obtained before sedation or premedication where the patient's capacity is affected.

  • Contraindications: active infection at site, thrombosis of target vein, ipsilateral mastectomy with lymphoedema, arteriovenous fistula arm, and inability to obtain consent in a patient lacking capacity without legal framework.

  • Anticoagulation management: assess last dose and renal function; ultrasound-guided technique reduces arterial puncture risk but does not eliminate bleeding risk.

  • Site selection rule: use the dominant arm where possible, avoid antecubital crease for long dwell, and assess both arms with ultrasound if first attempt fails.

  • Pre-procedure checklist: identity, allergies, consent, vein mapping, equipment availability, sterile field preparation, and rescue equipment (including ultrasound and tip confirmation device).

Quick reference

Infection Prevention, Asepsis, and Sterile Technique

  • Maximal sterile barrier precautions for central line insertion: sterile gown, sterile gloves, cap, mask, and full-body sterile drape.

  • Skin antisepsis: 2% chlorhexidine in 70% alcohol is preferred; allow to dry completely (typically 30 seconds for skin, longer for moist sites) before puncture.

  • Hand hygiene per WHO 5 Moments; alcohol-based rub for routine, soap and water for visible soiling and spore-forming organisms (e.g. C. difficile).

  • Hub disinfection: scrub the access port with 70% alcohol or chlorhexidine for at least 15 seconds and allow to dry before accessing.

  • Aseptic non-touch technique (ANTT) distinguishes key parts (must remain sterile) from non-key parts; key parts are protected throughout.

  • Dressing: sterile transparent semi-permeable dressing changed every 7 days, or sooner if soiled, loose, or damp; gauze dressings changed every 2 days.

  • Catheter-related bloodstream infection (CRBSI) diagnosis: same organism from peripheral blood and catheter tip or differential time to positivity; requires culture before antibiotic initiation.

  • Insertion site selection: avoid femoral site for central access where possible due to higher infection and thrombosis risk; subclavian has lower infection but higher pneumothorax risk.

Quick reference

Peripheral Venous Access: Devices, Insertion, and Ultrasound Guidance

  • Peripheral cannula gauges: 14G (large, rapid flow), 16G, 18G, 20G, 22G, 24G (small, paediatric/neonate); choose the smallest gauge that meets flow requirement.

  • Flow rate is proportional to the fourth power of radius (Poiseuille); a 14G delivers far higher flow than a 22G at the same pressure.

  • Ultrasound-guided peripheral cannulation: identify vein in short axis, confirm compressibility, enter at 15–30° angle, watch needle tip enter the lumen, then thread the cannula.

  • Tip visualisation: in short-axis view, confirm needle tip by seeing the tip indent the vein wall; avoid advancing without tip identification to prevent through-and-through puncture.

  • Deeper veins may require a longer cannula (e.g. 48 mm) to reach the lumen; standard 25 mm cannula may be inadequate at depth >1 cm.

  • Site selection: dorsum of hand, forearm, and antecubital fossa; avoid areas of flexion, joints, and previously infected or phlebitic sites.

  • Peripheral cannula dwell: remove and re-site if no longer clinically indicated; routine replacement every 72–96 hours is not required if the device is functioning and asymptomatic.

  • Phlebitis grading (VIP score): 0 = none, 1 = erythema at site, 2 = pain/erythema, 3 = pain/erythema/induration, 4 = pain/erythema/induration/palpable cord, 5 = purulent discharge.

Quick reference

Central Venous Access and Peripherally Inserted Central Catheters

  • PICC insertion sites: basilic, cephalic, or brachial vein; basilic is largest and most commonly used, cephalic has smaller diameter and more valves.

  • Tip confirmation: intracavitary ECG (IC-ECG) and/or chest radiograph; IC-ECG detects the P-wave change at the cavoatrial junction and is increasingly used as primary confirmation.

  • CICC sites: internal jugular (preferred for lower pneumothorax risk), subclavian, femoral; landmark or ultrasound-guided technique.

  • Seldinger technique: needle puncture, guidewire insertion, dilator, catheter over wire, wire removal, confirmation of blood flow, securement.

  • Catheter tip should terminate in the lower SVC or cavoatrial junction; tip in the right atrium increases arrhythmia and tamponade risk.

  • PICC diameter: 4Fr–6Fr typical; choose the smallest lumen number and diameter that meets therapy needs to reduce thrombosis risk.

  • Power-injectable PICCs are rated for contrast injection at specified flow rates (e.g. 5 mL/s); non-power-injectable catheters must never be used for power injection.

  • Tunnelled catheters and implanted ports are indicated for long-term therapy (months to years), chemotherapy, and repeated blood sampling.

Quick reference

Complications, Recognition, and Emergency Management

  • Air embolism: sudden dyspnoea, chest pain, hypotension; management is left lateral Trendelenburg position, 100% oxygen, and urgent medical review.

  • Catheter-related thrombosis: unilateral swelling, pain, collateral veins; confirm with duplex ultrasound and discuss anticoagulation and catheter removal.

  • Arterial puncture: pulsatile bright red blood, pain, haematoma; remove needle, apply pressure for at least 5–10 minutes (longer if anticoagulated), and escalate.

  • Pneumothorax after CICC: pleuritic chest pain, dyspnoea, reduced breath sounds; confirm with chest radiograph and manage per severity.

  • Catheter fracture or embolism: stop infusion, do not flush, apply a tourniquet proximally if peripheral, and arrange urgent retrieval.

  • Infiltration and extravasation: stop infusion, aspirate residual drug if possible, remove cannula, elevate limb, apply cold or warm compress per drug protocol, and document.

  • Cardiac arrhythmia during insertion: caused by guidewire or catheter in the right atrium; withdraw device and reposition, monitor ECG.

  • Phlebitis and infection: remove the device if severe phlebitis or suspected infection; culture the tip and obtain blood cultures before antibiotics.

Quick reference

Device Maintenance, Care, and Removal

  • Flush protocol: pulsatile flush with 10 mL or larger syringe for central catheters to reduce pressure damage; use positive pressure technique to prevent reflux.

  • Syringe size rule: never use a syringe smaller than 10 mL on a central catheter; small syringes generate high pressure and can rupture the catheter.

  • Lock solutions: heparinised saline (commonly 10 units/mL) or 0.9% sodium chloride per local policy; use saline for most peripheral cannulas.

  • Dressing change frequency: transparent semi-permeable every 7 days; gauze every 2 days; replace immediately if damp, loose, or soiled.

  • Securement: sutureless securement devices reduce migration and infection compared with sutures; use a stabilisation device plus dressing.

  • Removal: stop infusion, remove dressing and securement, withdraw catheter smoothly, apply pressure until haemostasis, inspect catheter integrity, and document.

  • Catheter integrity check on removal: confirm full length; if a fragment is missing, escalate for imaging and retrieval.

  • Blood sampling from central catheters: discard the first 2–3 mL (or per policy), then collect; avoid sampling from lines infusing incompatible drugs.

Quick reference

Documentation, Quality Assurance, and Clinical Governance

  • Minimum insertion documentation: date/time, operator, device type and gauge, site, number of attempts, ultrasound use, tip confirmation method and result, and patient tolerance.

  • Maintenance documentation: dressing change date, flush and lock, site assessment, and any complications or interventions.

  • Quality indicators: insertion success rate, first-attempt success, CRBSI rate per 1000 catheter-days, thrombosis rate, and complication rates.

  • Audit cycle: define standard, measure practice, compare with standard, implement change, re-audit; document findings and actions.

  • Incident reporting: all complications, near misses, and device failures should be reported through the local incident system for learning.

  • Competency maintenance: logbook of insertions, observed assessments, and annual update; scope of practice is defined by local policy and credentialing.

  • Consent and capacity documentation: record who consented, the discussion, and any legal framework used for patients lacking capacity.

  • Device registry and traceability: record lot numbers and device details for recall and infection investigation.

Quick reference

Professional, Ethical, and Legal Aspects of Practice

  • Duty of care: practitioners must act within their competence, seek supervision when needed, and escalate concerns about patient safety.

  • Consent law: valid consent requires capacity, sufficient information, and voluntariness; document the discussion and the patient's decision.

  • Mental capacity: assume capacity unless proven otherwise; assess understanding, retention, and communication of decision; use best-interests framework if lacking.

  • Confidentiality: share information on a need-to-know basis; disclose only with consent or where legally required (e.g. public health, court order).

  • Accountability: professional registration bodies (e.g. NMC, HCPC) require honesty, record-keeping, and reporting of errors.

  • Advocacy: raise concerns about unsafe practice through appropriate channels (line manager, freedom to speak up guardian, regulator).

  • Equality and non-discrimination: provide reasonable adjustments for disability, language, and cultural needs; use interpreters where required.

  • Scope of practice: expanding skills requires formal training, competency assessment, and governance approval; practising outside scope is a professional and legal risk.